![](/img/cover-not-exists.png)
High-dose myeloablative radioimmunotherapy of mantle cell non-hodgkin lymphoma with the iodine-131–labeled chimeric anti-CD20 antibody C2B8 and autologous stem cell support. [THIS ARTICLE HAS BEEN RETRACTED] : Results of a pilot study
Thomas M. Behr, Frank Griesinger, Joachim Riggert, Stefan Gratz, Martin Béhé, Cornelia C. Kaufmann, Bernhard Wörmann, Gerhard Brittinger, Wolfgang BeckerVolume:
94
Year:
2002
Language:
english
Pages:
10
DOI:
10.1002/cncr.10307
File:
PDF, 1.62 MB
english, 2002